[BCG therapy of recurrent herpes simplex type 1 and 2 (HSV-1 and 2)].
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000302:isolation & purification; D000917:Antibody Formation; D001500:BCG Vaccine / Q000627:therapeutic use*; D002908:Chronic Disease; D003176:Complement C3 / Q000302:isolation & purification; D006561:Herpes Simplex / Q000276:immunology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013997:Time Factors
D000914:Antibodies, Viral; D001500:BCG Vaccine; D003176:Complement C3
BCG-Therapie bei rezidivierendem Herpes simplex Typ 1 und 2 (HSV-1 und 2).